Cerapedics Print Logo

Upcoming Events


In the News


November 23, 2015

Cerapedics: A PMA First Opens New Opportunities in Cervical Spine Osteobiologics  More


November 3, 2015

Cerapedics Receives FDA Approval for i-FACTOR™ Peptide Enhanced Bone Graft in Cervical Spine Surgery More


June 16, 2015

Cerapedics Announces FDA Advisory Committee Panel Is Not Required for i-FACTOR™ PMA Approval More


April 7, 2015

Cerapedics Announces Closing of Loan and Equity Financing More


February 19, 2015

Study Supports Use of Cerapedics i‐FACTOR™ Biologic Bone Graft as Alternative to Autograft in Common Spine Surgery for Chronic Back Pain More


January 14, 2015

Cerapedics Receives CE Mark and TGA Listing for New i‐FACTOR™ Flex FR Biologic Bone Graft More


October 20, 2014

Novel i‐FACTOR™ Biologic Bone Graft Shown to Improve Clinical Outcomes in ALIF Procedures More


September 4, 2014

Cerapedics Files Premarket Approval Application With US FDA for I-Factor™ Peptide Enhanced Bone Graft  More


April 14, 2014

Cerapedics Announces Closing Of Venture Debt Loan From GE Capital  More


March 11, 2014

Cerapedics Announces Positive Results From IDE Clinical Trial  More


March 4, 2014

Cerapedics to present preliminary outcomes data from i-FACTOR™ Bone Graft Study at Canaccord Genuity Musculoskeletal Conference  More


April 13, 2013

Cerapedics Appoints Glen A. Kashuba as Chief Exectutive Officer and Jeffrey G. Marx, PhD as President and Chief Operating Officer More


March 12, 2013

Cerapedics Adds New Board Member Antony Koblish More

March 4, 2013

Cerapedics Announces 10,000th Patient Treated With i-FACTOR™ Peptide Enhanced Bone Graft More

December 12, 2012

Cerapedics Secures $19 Million Series C

November 9, 2011

Cerapedics granted patent protecting the method of manufacture for i-FACTOR™ biologic bone graft in Lyophilized forms. More

April 11, 2011

Prospective, Randomized, Controlled Trial Demonstrates 98% Fusion Rate at 6-months and 12-months with i-FACTOR™ Biologic Bone Graft and Superiority versus Autograft in Single- and Multi-Level PLIF Spine Surgery More

June 30, 2010

i-FACTOR Flex Receives CE Mark. Cerapedics announced that it received the CE Mark for its i-FACTOR™ Flex bone graft product line. More

Media Inquiries

For more information, the press is invited to contact Cerapedics at info@cerapedics.com